For the Inventor, By the Inventor

Enter assignee name

Claremont, CA, United States of America

Synedgen, Inc.

USPTO Granted Patents = 20

CIPO Patents = 3

EPO Patents = 10

Trademarks = 9

Forward Citations = 103

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

William P Wiesmann (20 out of 36 patents)

Shenda M Baker (20 out of 21 patents)

Stacy M Townsend (6 out of 6 patents)

4. Ruth Baxter (2 out of 2 patents)

5. Shannon Ryan (1 out of 2 patents)

6. Shena D Baker (0 patent)

20 patents: Sort by Forward Citations

1. 12465616 - Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds (2025-11-11),

2. 11975018 - Methods for treatment or prevention of damage resulting from radiation, trauma or shock (2024-05-07),

3. 11957707 - Compositions and methods of use thereof (2024-04-16),

4. 11911412 - Derivatized chitosan polymers and methods of treating vascular disorders (2024-02-27),

5. 11786547 - Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds (2023-10-17),

6. 11717532 - Methods and compositions for treating wounds utilizing chitosan compounds (2023-08-08),

7. 11433092 - Compositions and methods of use for wound healing (2022-09-06),

8. 11077135 - Derivatized chitosan polymers and methods of treating vascular disorders (2021-08-03),

9. 10765616 - Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar (2020-09-08),

10. 10716803 - Methods for treatment or prevention of damage resulting from radiation, trauma or shock (2020-07-21),

11. 10494451 - Chitosan-derivative compounds and methods of controlling microbial populations (2019-12-03),

12. 10022393 - Methods for treatment or prevention of damage resulting from radiation, trauma or shock (2018-07-17),

13. 9732164 - Chitosan-derivative compounds and methods of controlling microbial populations (2017-08-15),

14. 9439925 - Methods and compositions for treating wounds utilizing chitosan compounds (2016-09-13),

15. 9234050 - Chitosan derivatives to treat animals or optimize animal health (2016-01-12),

Synedgen, Inc. is a biopharmaceutical company that develops and commercializes novel therapeutics and products for the treatment of inflammation, infection, and healing. Their advanced glycomics technology platform produces drugs and medical devices that address unmet medical needs in a wide range of applications. With a focus on improving patient outcomes and reducing healthcare costs, Synedgen strives to make a positive impact on the medical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

20 Patents

#2 in Claremont, CA

#3,810 in California

#15,887 in US

#30,350 in the World

Claremont, CA, United States of America

Synedgen, Inc.

Forward Citations = 103

5 inventors:

William P Wiesmann (20 out of 36 patents)

Shenda M Baker (20 out of 21 patents)

Stacy M Townsend (6 out of 6 patents)

4. Ruth Baxter (2 out of 2 patents)

5. Shannon Ryan (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…